- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02398812
The Interprofessional Medication Assessment for Older Patients
The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Forssa, Finland, FI 30100
- Welfare district of Forssa
-
Haapajärvi, Finland, FI 85800
- Selänne Basic Health Care District
-
Juva, Finland, FI-51900
- Juva Health Care
-
Lahti, Finland, FI-15100
- City of Lahti, home care
-
Savonlinna, Finland, FI-57100
- Eastern Savo Hospital District
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
|
Intervention
|
Ingen indgriben: Usual care
Usual care (reference group).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Functional capacity IADL (Instrumental Activities of Daily Living)
Tidsramme: at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity ADL (Activities of daily living;KATZ)
Tidsramme: at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity TUG (Timed up and go)
Tidsramme: at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity MMSE ( Mini-mental state examination)
Tidsramme: at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity GDS (Geriatric Depression Scale)-15
Tidsramme: at 6 months from baseline
|
at 6 months from baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Use of health care services
Tidsramme: at 6 and 12 months from baseline
|
visits to physician, hospital days and nursing care at home
|
at 6 and 12 months from baseline
|
Need of services delivered to home
Tidsramme: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Number of medicines
Tidsramme: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Quality of medicines
Tidsramme: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Cost of medicines
Tidsramme: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Health related quality of life assessed with EQ-5D
Tidsramme: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studiestol: Pekka Mäntyselkä, MD, professor
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- ILMA
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .